Resumo

MALBRAN, Alejandro et al. Conjuntivitis cicatrizal recalcitrante: Tratamiento de nueve pacientes con rituximab. Medicina (B. Aires) [online]. 2019, vol.79, n.4, pp.299-302. ISSN 0025-7680.

Cicatrizing conjunctivitis is the final consequence of several diseases. The most severe among them are cicatricial pemphigoid and chronic Stevens-Johnson syndrome. Systemic immunosuppressive drugs and steroids are usually an effective approach to these diseases. However, a few patients follow a recalcitrant course unremitting to usual therapy. We describe the treatment with rituximab of seven patients with cicatricial pemphigoid and two with chronic Stevens-Johnson syndrome. Eight of them also received gammaglobulin and all achieved clinical remission. Three relapsed and required two or three new courses of rituximab with good control of disease activity. Rituximab proved to be an efficacious drug for chronic recalcitrant cicatrizing conjunctivitis.

Palavras-chave : Cicatrizing conjunctivitis; Pemphigoid; Stevens-Johnson; Rituximab.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )